Attention-deficit/hyperactivity disorder (ADHD) is a relatively common psychiatric condition characterized by persistent inattention, hyperactivity, and impulsivity. Pooled estimates from meta-analyses suggest that ADHD affects approximately 5.3% of the general population (6.5% of children) and is 4 times more common in boys.
1 In 2013, the World Health Organization estimated that 39 million people worldwide are affected.
2 Attention-deficit/hyperactivity disorder is associated with comorbid conditions, including low self-esteem, mood disorders, substance abuse, learning disabilities, and disruptive behavior disorders.
3-5 Compared with the costs for unaffected children, the health care costs for children with ADHD are double—quadruple among those with comorbid mental health disorders.
6 The annual health- and work-related costs of ADHD in the United States total $32 billion.
7 No cure has yet been identified, but symptoms can be managed using medication: methylphenidate hydrochloride, dexamphetamine sulfate, lisdexamphetamine dimesylate, atomoxetine, and guanfacine hydrochloride. Children with ADHD are more prone to difficulties with reading, writing, and executive function,
8-11 but medication may improve concentration by controlling impulsivity and promoting calmness.
12